President Uhuru Kenyatta has announced 213 new cases of COVID-19.
Addressing the nation from State House the hard of state said that the total number of infections has as a result risen to 33,016.
241 others, he confirmed, had recovered from the novel COVID-19 in the last 24 hours.
This pushes the number of recoveries to 19,296.
On a sad note, 5 other patients lost their lives to the invisible enemy.
The death toll as a result stands at 564.
Uhuru told Kenyans that the rate of infection has gone down from 13% in June to 8 percent in the month of August.
“We note the good progress we have made so far in fighting this enemy, but, this positive news is no license for us to drop guard and backslide from our path of responsibility,” he said.
He did however note that the country continues to face problems in the fight against the pandemic.
While the spread has slowed down in hotspots like Nairobi and Mombasa, the virus has spread to the counties.
“The new frontier of this invisible enemy is increasingly shifting to the counties and rural areas.
“Whereas there is no doubt, notable expansion of the health sector architecture has taken place in the counties, more needs to be done. And the pace of this expansion should be increased in order to cope with the gradual shift of this pandemic to the counties,” he said.
He also directed the Health CS Mutahi Kagwe and the Council of Governors chairperson (CoG) Wycliffe Oparanya to constitute a National Reference Group on COVID-19 which will review Kenya’s response to the pandemic thus far.
“The group should formulate strategies to identify institutional weaknesses within healthcare system at both tiers; recommend ways to increase the representation of the County Governments in the Boards of Healthcare Agencies; and recommend ways in which our national responses to healthcare emergencies can be improved.
“The National Reference Group on COVID-19 should position healthcare as a driver of our manufacturing agenda by ensuring that preference is given to local manufacturers in the procurement of pharmaceuticals and non-pharmaceutical products,” the head of state directed.
The reference group will also be tasked with establishing a COVID-19 Vaccine Consortium which will focus on the development and testing of COVID-19 vaccine locally.